Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sun Grapples With Impact Of Halol FDA Import Alert
US Supplies From Non-Compliant Plant Account For 3% Of Annual Sales
Dec 13 2022
•
By
Dave Wallace
Sun’s Halol plant is once again under FDA scrutiny • Source: Shutterstock
More from Manufacturing
More from Business